Molecular dynamics during reduction of TKI dose reliably identify molecular recurrence after treatment cessation in CML.


Gottschalk, Andrea, Glauche, Ingmar, Cicconi, Silvia ORCID: 0000-0001-5507-6203, Clark, Richard E ORCID: 0000-0002-1261-3299 and Roeder, Ingo (2020) Molecular dynamics during reduction of TKI dose reliably identify molecular recurrence after treatment cessation in CML. Blood, 135 (10). pp. 766-769.

[img] Text
Molecular dynamics in DESTINY.pdf - Author Accepted Manuscript
Download (1MB) | Preview
Item Type: Article
Uncontrolled Keywords: Humans, Recurrence, Protein Kinase Inhibitors, Drug Monitoring, Prognosis, Withholding Treatment, Remission Induction, Molecular Diagnostic Techniques, Dose-Response Relationship, Drug, Clinical Trials as Topic, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Progression-Free Survival
Depositing User: Symplectic Admin
Date Deposited: 11 Mar 2020 16:53
Last Modified: 18 Jan 2023 23:58
DOI: 10.1182/blood.2019003395
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3078638
Dimensions
Altmetric
CORE (COnnecting REpositories)